Literature DB >> 11991687

Carotid artery disease and stroke during coronary artery bypass: a critical review of the literature.

A R Naylor1, Z Mehta, P M Rothwell, P R F Bell.   

Abstract

OBJECTIVES: to determine the role of carotid artery disease in the pathophysiology of stroke after coronary artery bypass (CABG).
DESIGN: systematic review of the literature.
RESULTS: the risk of stroke after CABG was 2% and remained unchanged between 1970-2000. Two-thirds occurred after day 1 and 23% died. 91% of screened CABG patients had no significant carotid disease and had a <2% risk of peri-operative stroke. Stroke risk increased to 3% in predominantly asymptomatic patients with a unilateral 50-99% stenosis, 5% in those with bilateral 50-99% stenoses and 7-11% in patients with carotid occlusion. Significant predictive factors for post-CABG stroke included; (i) carotid bruit (OR 3.6, 95% CI 2.8-4.6), (ii) prior stroke/TIA (OR 3.6, 95% CI 2.7-4.9) and (iii) severe carotid stenosis/occlusion (OR 4.3, 95% CI 3.2-5.7). However, the systematic review indicated that 50% of stroke sufferers did not have significant carotid disease and 60% of territorial infarctions on CT scan/autopsy could not be attributed to carotid disease alone.
CONCLUSIONS: carotid disease is an important aetiological factor in the pathophysiology of post-CABG stroke. However, even assuming that prophylactic carotid endarterectomy carried no additional risk, it could only ever prevent about 40-50% of procedural strokes. Copyright 2002 Harcourt Publishers Limited.

Entities:  

Mesh:

Year:  2002        PMID: 11991687     DOI: 10.1053/ejvs.2002.1609

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  53 in total

1.  Current outcomes of simultaneous carotid endarterectomy and coronary artery bypass graft surgery in North America.

Authors:  Sunil M Prasad; Shuang Li; J Scott Rankin; Sean M O'Brien; James S Gammie; John D Puskas; David M Shahian; Edgar G Chedrawy; Malek G Massad
Journal:  World J Surg       Date:  2010-10       Impact factor: 3.352

Review 2.  Management of combined severe carotid and coronary artery disease.

Authors:  Marco Roffi; Flavio Ribichini; Fausto Castriota; Alberto Cremonesi
Journal:  Curr Cardiol Rep       Date:  2012-04       Impact factor: 2.931

Review 3.  Non-cardiac vascular disease.

Authors:  Thomas W G Carrell; John H N Wolfe
Journal:  Heart       Date:  2005-02       Impact factor: 5.994

4.  Coronary angiography in patients undergoing carotid artery stenting shows a high incidence of significant coronary artery disease.

Authors:  R Hofmann; A Kypta; C Steinwender; K Kerschner; M Grund; F Leisch
Journal:  Heart       Date:  2005-03-10       Impact factor: 5.994

5.  Management of asymptomatic carotid stenosis in patients undergoing general and vascular surgical procedures.

Authors:  M Paciaroni; V Caso; M Acciarresi; R W Baumgartner; G Agnelli
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-10       Impact factor: 10.154

Review 6.  Neurologic complications of cardiac surgery: current concepts and recent advances.

Authors:  David J Bronster
Journal:  Curr Cardiol Rep       Date:  2006-02       Impact factor: 2.931

Review 7.  Stroke associated with coronary artery bypass grafting.

Authors:  Keiji Oi; Hirokuni Arai
Journal:  Gen Thorac Cardiovasc Surg       Date:  2015-07-08

8.  Multisystem revascularization.

Authors:  Zehra Jaffery; Arthur Grant
Journal:  Ochsner J       Date:  2009

9.  Cerebral lesions in patients undergoing coronary artery bypass grafting in relation to asymptomatic carotid and vertebral artery stenosis.

Authors:  Sebastian Wiberg; Mikkel Schoos; Henrik Sillesen; Carsten Thomsen; Christian Hassager; Daniel Steinbrüchel; Torben Schroeder; Peter Clemmensen; Henning Kelbæk
Journal:  Ann Vasc Dis       Date:  2015-03-09

10.  Effect of carotid revascularization on cerebral autoregulation in combined cardiac surgery†.

Authors:  Daijiro Hori; Masahiro Ono; Hideo Adachi; Charles W Hogue
Journal:  Eur J Cardiothorac Surg       Date:  2015-02-01       Impact factor: 4.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.